Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2012

01-10-2012 | Article

Epidemiology of Acinetobacter spp.-associated healthcare infections and colonization among children at a tertiary-care hospital in Saud Arabia: a 6-year retrospective cohort study

Authors: H. H. Balkhy, M. S. Bawazeer, R. F. Kattan, H. M. Tamim, S. M. Al Johani, F. A. Aldughashem, H. A. Al Alem, A. Adlan, L. A. Herwaldt

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2012

Login to get access

Abstract

A retrospective cohort study was conducted among hospitalized children less than 12 years of age who had Acinetobacter spp. isolated from ≥1 cultures between October 2001 and December 2007 at King Abdulaziz Medical City in Riyadh, Saudi Arabia. Children with multidrug-resistant (MDR) Acinetobacter spp. healthcare-associated infections (HAIs) were compared to children with antimicrobial-susceptible Acinetobacter spp. HAIs and to children colonized with Acinetobacter. Children with MDR Acinetobacter spp. HAIs were older (p = 0.01), more likely to be admitted to an intensive care unit (ICU) (p = 0.06), and had a higher mortality rate (p = 0.02) than colonized children. Children with MDR Acinetobacter spp. HAIs were older than children with antimicrobial-susceptible Acinetobacter spp. HAIs (p = 0.0004), but their mortality rates were similar. Among children with MDR Acinetobacter spp. HAIs, burn injuries were the most common underlying illness. HAIs caused by MDR or susceptible Acinetobacter spp. occurred after prolonged hospitalization, suggesting nosocomial acquisition. Patients infected with MDR Acinetobacter spp. frequently received inappropriate empiric therapy (73.9 %). Further studies are needed in order to identify effective strategies to prevent nosocomial transmission and effective ways of improving patient outcomes.
Literature
1.
go back to reference Hirai Y (1991) Survival of bacteria under dry conditions; from a viewpoint of nosocomial infection. J Hosp Infect 19(3):191–200PubMedCrossRef Hirai Y (1991) Survival of bacteria under dry conditions; from a viewpoint of nosocomial infection. J Hosp Infect 19(3):191–200PubMedCrossRef
2.
go back to reference Hu J, Robinson JL (2010) Systematic review of invasive Acinetobacter infections in children. Can J Infect Dis Med Microbiol 21(2):83–88PubMed Hu J, Robinson JL (2010) Systematic review of invasive Acinetobacter infections in children. Can J Infect Dis Med Microbiol 21(2):83–88PubMed
3.
go back to reference Katragkou A, Kotsiou M, Antachopoulos C, Benos A, Sofianou D, Tamiolaki M, Roilides E (2006) Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: a case–control study. Intensive Care Med 32(9):1384–1391PubMedCrossRef Katragkou A, Kotsiou M, Antachopoulos C, Benos A, Sofianou D, Tamiolaki M, Roilides E (2006) Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: a case–control study. Intensive Care Med 32(9):1384–1391PubMedCrossRef
4.
go back to reference Karageorgopoulos DE, Falagas ME (2008) Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 8(12):751–762PubMedCrossRef Karageorgopoulos DE, Falagas ME (2008) Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 8(12):751–762PubMedCrossRef
5.
go back to reference Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, Cosgrove SE, Anderson A, Carnell J, Jernigan DB, Kleinbaum DG, Perl TM, Standiford HC, Srinivasan A (2007) Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 13(1):97–103PubMedCrossRef Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, Cosgrove SE, Anderson A, Carnell J, Jernigan DB, Kleinbaum DG, Perl TM, Standiford HC, Srinivasan A (2007) Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 13(1):97–103PubMedCrossRef
6.
go back to reference Hsueh PR, Chen WH, Luh KT (2005) Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991–2003 at a university hospital in Taiwan. Int J Antimicrob Agents 26(6):463–472PubMedCrossRef Hsueh PR, Chen WH, Luh KT (2005) Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991–2003 at a university hospital in Taiwan. Int J Antimicrob Agents 26(6):463–472PubMedCrossRef
7.
go back to reference Morgan DJ, Liang SY, Smith CL, Johnson JK, Harris AD, Furuno JP, Thom KA, Snyder GM, Day HR, Perencevich EN (2010) Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers. Infect Control Hosp Epidemiol 31(7):716–721PubMedCrossRef Morgan DJ, Liang SY, Smith CL, Johnson JK, Harris AD, Furuno JP, Thom KA, Snyder GM, Day HR, Perencevich EN (2010) Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers. Infect Control Hosp Epidemiol 31(7):716–721PubMedCrossRef
8.
go back to reference Corbella X, Pujol M, Ayats J, Sendra M, Ardanuy C, Domínguez MA, Liñares J, Ariza J, Gudiol F (1996) Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin Infect Dis 23(2):329–334PubMedCrossRef Corbella X, Pujol M, Ayats J, Sendra M, Ardanuy C, Domínguez MA, Liñares J, Ariza J, Gudiol F (1996) Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin Infect Dis 23(2):329–334PubMedCrossRef
9.
go back to reference Ayats J, Corbella X, Ardanuy C, Domínguez MA, Ricart A, Ariza J, Martin R, Liñares J (1997) Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients. J Hosp Infect 37(4):287–295PubMedCrossRef Ayats J, Corbella X, Ardanuy C, Domínguez MA, Ricart A, Ariza J, Martin R, Liñares J (1997) Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients. J Hosp Infect 37(4):287–295PubMedCrossRef
10.
go back to reference Thom KA, Hsiao WW, Harris AD, Stine OC, Rasko DA, Johnson JK (2010) Patients with Acinetobacter baumannii bloodstream infections are colonized in the gastrointestinal tract with identical strains. Am J Infect Control 38(9):751–753PubMedCrossRef Thom KA, Hsiao WW, Harris AD, Stine OC, Rasko DA, Johnson JK (2010) Patients with Acinetobacter baumannii bloodstream infections are colonized in the gastrointestinal tract with identical strains. Am J Infect Control 38(9):751–753PubMedCrossRef
11.
go back to reference Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36(5):309–332PubMedCrossRef Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36(5):309–332PubMedCrossRef
12.
go back to reference SAS Release 9.1. (2002) SAS Institute Inc., Cary, NC, USA SAS Release 9.1. (2002) SAS Institute Inc., Cary, NC, USA
13.
go back to reference Kaye KS, Engemann JJ, Mozaffari E, Carmeli Y (2004) Reference group choice and antibiotic resistance outcomes. Emerg Infect Dis 10(6):1125–1128PubMedCrossRef Kaye KS, Engemann JJ, Mozaffari E, Carmeli Y (2004) Reference group choice and antibiotic resistance outcomes. Emerg Infect Dis 10(6):1125–1128PubMedCrossRef
14.
go back to reference Bilavsky E, Schwaber MJ, Carmeli Y (2010) How to stem the tide of carbapenemase-producing enterobacteriaceae?: proactive versus reactive strategies. Curr Opin Infect Dis 23(4):327–331PubMedCrossRef Bilavsky E, Schwaber MJ, Carmeli Y (2010) How to stem the tide of carbapenemase-producing enterobacteriaceae?: proactive versus reactive strategies. Curr Opin Infect Dis 23(4):327–331PubMedCrossRef
15.
go back to reference Ben-David D, Maor Y, Keller N, Regev-Yochay G, Tal I, Shachar D, Zlotkin A, Smollan G, Rahav G (2010) Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 31(6):620–626PubMedCrossRef Ben-David D, Maor Y, Keller N, Regev-Yochay G, Tal I, Shachar D, Zlotkin A, Smollan G, Rahav G (2010) Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 31(6):620–626PubMedCrossRef
16.
go back to reference Dealler S (1998) Nosocomial outbreak of multi-resistant Acinetobacter sp. on an intensive care unit: possible association with ventilation equipment. J Hosp Infect 38(2):147–148PubMedCrossRef Dealler S (1998) Nosocomial outbreak of multi-resistant Acinetobacter sp. on an intensive care unit: possible association with ventilation equipment. J Hosp Infect 38(2):147–148PubMedCrossRef
17.
go back to reference Catalano M, Quelle LS, Jeric PE, Di Martino A, Maimone SM (1999) Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases. J Hosp Infect 42(1):27–35PubMedCrossRef Catalano M, Quelle LS, Jeric PE, Di Martino A, Maimone SM (1999) Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases. J Hosp Infect 42(1):27–35PubMedCrossRef
18.
go back to reference Michalopoulos A, Falagas ME (2010) Treatment of Acinetobacter infections. Expert Opin Pharmacother 11(5):779–788PubMedCrossRef Michalopoulos A, Falagas ME (2010) Treatment of Acinetobacter infections. Expert Opin Pharmacother 11(5):779–788PubMedCrossRef
19.
go back to reference Falagas ME, Kasiakou SK, Rafailidis PI, Zouglakis G, Morfou P (2006) Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy. J Antimicrob Chemother 57(6):1251–1254PubMedCrossRef Falagas ME, Kasiakou SK, Rafailidis PI, Zouglakis G, Morfou P (2006) Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy. J Antimicrob Chemother 57(6):1251–1254PubMedCrossRef
Metadata
Title
Epidemiology of Acinetobacter spp.-associated healthcare infections and colonization among children at a tertiary-care hospital in Saud Arabia: a 6-year retrospective cohort study
Authors
H. H. Balkhy
M. S. Bawazeer
R. F. Kattan
H. M. Tamim
S. M. Al Johani
F. A. Aldughashem
H. A. Al Alem
A. Adlan
L. A. Herwaldt
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1608-8

Other articles of this Issue 10/2012

European Journal of Clinical Microbiology & Infectious Diseases 10/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine